Drug Profile
RJR 1781
Alternative Names: TC 1781Latest Information Update: 11 Oct 2004
Price :
$50
*
At a glance
- Originator Targacept
- Class Small molecules
- Mechanism of Action Dopamine release stimulants; Nicotinic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease; Parkinson's disease
Most Recent Events
- 30 Sep 2004 Discontinued - Preclinical for Alzheimer's disease in USA (unspecified route)
- 30 Sep 2004 Discontinued - Preclinical for Parkinson's disease in USA (unspecified route)
- 30 Aug 2004 Aventis has merged with Sanofi-Synthélabo to form Sanofi-Aventis